<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" orientation="portrait" position="anchor">
 <label>Table 1. </label>
 <caption>
  <title>Examples of HIV assay development and related research studies supported by CEPHIA.</title>
 </caption>
 <table frame="hsides" rules="groups" content-type="article-table">
  <thead>
   <tr>
    <th align="left" valign="top" rowspan="1" colspan="1">Study type</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Examples</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <bold>Focused hypothesis-driven studies</bold>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">•  How the gut inflammasome and specific HIV antibody subclasses 
     <break/>change as HIV infection evolves 
     <break/>•  How timing of treatment initiation after HIV infection impacts kinetics 
     <break/>of HIV reservoir seeding and opportunity for cure
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <bold>Non-hypothesis-driven efforts to identify</bold>
     <break/>
     <bold>novel signatures of recent HIV infection</bold>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">•  Searches for antibodies reactive to peptoids in a large ‘peptoid 
     <break/>shape library’ 
     <break/>•  Multiplexed assay utilizing viral and antibody markers identified and 
     <break/>interpreted through a machine learning algorithm
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <bold>CDC and NIH funded projects</bold>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">•  Examination of the factors in HIV resistance, including mutation, 
     <break/>selection, recombination, and drift 
     <break/>•  Development of a single genomic assay for HIV incidence and 
     <break/>transmitted drug resistance mutation screening 
     <break/>•  Independent evaluation of the Sedia Asanté™ HIV-1 Rapid 
     <break/>Recency® Assay, currently in use by PEPFAR at international sites
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <bold>Theoretical and toolkit innovations</bold>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">•  Development of a theoretical framework and web-based tool for 
     <break/>consistent time of infection estimation based on subject-level 
     <break/>diagnostic testing histories and the properties of diagnostic assays
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
